Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial

Overview of attention for article published in Neuropsychopharmacology, October 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)

Mentioned by

twitter: 5 X users

reddit: 2 Redditors

Readers on

mendeley: 53 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 11,705 followers.

RCT: Compared to placebo, 20 and 50 mg of JNJ-48816274, an orexin-2 receptor antagonist, increased total sleep time, REM sleep duration and sleep efficiency, and reduced latency to persistent sleep, sleep onset latency, and REM latency https://t.co/RmMKA2…

New work on the impact of selective #orexin -2 receptor antagonist on #sleep. ⁦@vikki_revell⁩ https://t.co/W4PhlhmlO5

https://t.co/oUDMEaTNLb Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial #pharmacology #pharmacy

Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial https://t.co/iabH5WF3vJ https://t.co/YCLdhHEWiy

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.